Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05636215
Title A First-in-human Study of IBI354 in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Innovent Biologics (Suzhou) Co. Ltd.
Indications
Therapies
Age Groups: adult | senior
Covered Countries AUS

Facility Status City State Zip Country Details
Scientia Clinical Research Ltd NOT_YET_RECRUITING Randwick New South Wales 2031 Australia Details
Sunshine Coast University Private Hospital NOT_YET_RECRUITING Sunshine Coast Queensland 4575 Australia Details
Monash Health NOT_YET_RECRUITING Clayton Victoria 3168 Australia Details
Peking University Cancer Hospital RECRUITING Beijing Beijing 100142 China Details
Affiliated Cancer Hospital of Chongqing University RECRUITING Chongqing Chongqing 400030 China Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field